Phase 2 Advanced Tumors Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

DLL3-expressing TumorsAdvanced Tumors

Jonsson Comprehensive Cancer Center29 enrolled5 locationsNCT06788938

Recruiting

Phase 1Phase 2

Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors

Advanced Tumors

ModeX Therapeutics, An OPKO Health Company235 enrolled6 locationsNCT07110584

Recruiting

Phase 2

Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)

Advanced Tumors

The University of Hong Kong-Shenzhen Hospital154 enrolled2 locationsNCT06314087